The data indicate that miR17-92 cluster and its paralogs, miR-106a-363 and miR-106b-25, potentially target the cd242-SRF signaling pathway, thereby regulating the cardiac response to pathophysiological conditions, including hypertension, cardiac hypertrophy, heart failure, and arrhythmias. Here, SRF is linked to hypertensive disorder.